Giri T - Search Results

1

Ability of VKORC1 and CYP2C9 to predict therapeutic warfarin dose during the initial weeks of therapy.

Ferder NS, Eby CS, Deych E, Harris JK, Ridker PM, Milligan PE, Goldhaber SZ, King CR, Giri T, McLeod HL, Glynn RJ, Gage BF. Ferder NS, et al. Among authors: giri t. J Thromb Haemost. 2010 Jan;8(1):95-100. doi: 10.1111/j.1538-7836.2009.03677.x. Epub 2009 Oct 30. J Thromb Haemost. 2010. PMID: 19874474 Free PMC article. Clinical Trial.

2

Placental dermatan sulfate: isolation, anticoagulant activity, and association with heparin cofactor II.

Giri TK, Tollefsen DM. Giri TK, et al. Blood. 2006 Apr 1;107(7):2753-8. doi: 10.1182/blood-2005-09-3755. Epub 2005 Dec 8. Blood. 2006. PMID: 16339402 Free PMC article.

3

Vascular dermatan sulfate regulates the antithrombotic activity of heparin cofactor II.

He L, Giri TK, Vicente CP, Tollefsen DM. He L, et al. Blood. 2008 Apr 15;111(8):4118-25. doi: 10.1182/blood-2007-12-127928. Epub 2008 Feb 15. Blood. 2008. PMID: 18281504 Free PMC article.

4

Heparin cofactor II levels do not predict the development of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study.

Giri TK, Ahn CW, Wu KK, Tollefsen DM. Giri TK, et al. Arterioscler Thromb Vasc Biol. 2005 Dec;25(12):2689-90. doi: 10.1161/01.ATV.0000193888.71297.f3. Arterioscler Thromb Vasc Biol. 2005. PMID: 16306439 No abstract available.

5

Deficient APC-cofactor activity of protein S Heerlen in degradation of factor Va Leiden: a possible mechanism of synergism between thrombophilic risk factors.

Giri TK, Yamazaki T, Sala N, Dahlbäck B, de Frutos PG. Giri TK, et al. Blood. 2000 Jul 15;96(2):523-31. Blood. 2000. PMID: 10887114 Free article.

6

Protein S Thr103Asn mutation associated with type II deficiency reproduced in vitro and functionally characterised.

Giri TK, García de Frutos P, Dahlbäck B. Giri TK, et al. Thromb Haemost. 2000 Sep;84(3):413-9. Thromb Haemost. 2000. PMID: 11019964

7

A new direct, fast and quantitative enzyme-linked ligandsorbent assay for measurement of free protein S antigen.

Giri TK, Hillarp A, Härdig Y, Zöller B, Dahlbäck B. Giri TK, et al. Thromb Haemost. 1998 Apr;79(4):767-72. Thromb Haemost. 1998. PMID: 9569190

8

In vitro characterisation of two naturally occurring mutations in the thrombin-sensitive region of anticoagulant protein S.

Giri TK, de Frutos PG, Yamazaki T, Villoutreix BO, Dahlbäck B. Giri TK, et al. Thromb Haemost. 1999 Dec;82(6):1627-33. Thromb Haemost. 1999. PMID: 10613646

9

Topological studies of the amino terminal modules of vitamin K-dependent protein S using monoclonal antibody epitope mapping and molecular modeling.

Giri TK, Villoutreix BO, Wallqvist A, Dahlbäck B, de Frutos PG. Giri TK, et al. Thromb Haemost. 1998 Nov;80(5):798-804. Thromb Haemost. 1998. PMID: 9843174

10

Structural requirements of anticoagulant protein S for its binding to the complement regulator C4b-binding protein.

Giri TK, Linse S, García de Frutos P, Yamazaki T, Villoutreix BO, Dahlbäck B. Giri TK, et al. J Biol Chem. 2002 Apr 26;277(17):15099-106. doi: 10.1074/jbc.M103036200. Epub 2002 Feb 14. J Biol Chem. 2002. PMID: 11847209 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters